{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T10:30:43Z","timestamp":1780396243118,"version":"3.54.1"},"reference-count":119,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","jcehepatology.com","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical and Experimental Hepatology"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.jceh.2024.101432","type":"journal-article","created":{"date-parts":[[2024,5,22]],"date-time":"2024-05-22T06:54:37Z","timestamp":1716360877000},"page":"101432","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Recurrence of Primary Disease After Adult Liver Transplant \u2013 Risk Factors, Early Diagnosis, Management, and Prevention"],"prefix":"10.1016","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0007-0063","authenticated-orcid":false,"given":"Rohit","family":"Mehtani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6529-9080","authenticated-orcid":false,"given":"Sahaj","family":"Rathi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jceh.2024.101432_bib1","doi-asserted-by":"crossref","first-page":"2809","DOI":"10.1016\/j.cgh.2021.12.002","article-title":"2019 Global NAFLD prevalence: a systematic review and meta-analysis","volume":"20","author":"Le","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2024.101432_bib2","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1053\/j.gastro.2011.06.061","article-title":"Frequency and outcomes of liver transplantation for nonalcoholic steatohepatitis in the United States","volume":"141","author":"Charlton","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jceh.2024.101432_bib3","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/j.jceh.2021.11.010","article-title":"Prevalence of non-alcoholic fatty liver disease in India: a systematic review and meta-analysis","volume":"12","author":"Shalimar","year":"2022","journal-title":"J Clin Exp Hepatol"},{"key":"10.1016\/j.jceh.2024.101432_bib4","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1002\/lt.23499","article-title":"Evolution of nonalcoholic fatty liver disease recurrence after liver transplantation","volume":"18","author":"Patil","year":"2012","journal-title":"Liver Transplant"},{"key":"10.1016\/j.jceh.2024.101432_bib5","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1016\/j.jceh.2022.04.012","article-title":"Nonalcoholic fatty liver disease in living donor liver transplant recipients: a histology-based study","volume":"12","author":"Choudhary","year":"2022","journal-title":"J\u00a0Clin Exp Hepatol"},{"key":"10.1016\/j.jceh.2024.101432_bib6","doi-asserted-by":"crossref","first-page":"101281","DOI":"10.1016\/j.jceh.2023.09.002","article-title":"Post-transplant non-alcoholic fatty liver disease and metabolic syndrome after living donor liver transplantation in Indians","volume":"14","author":"Choudhary","year":"2024","journal-title":"J\u00a0Clin Exp Hepatol"},{"key":"10.1016\/j.jceh.2024.101432_bib7","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1002\/lt.21943","article-title":"Recurrent disease following liver transplantation for nonalcoholic steatohepatitis cirrhosis","volume":"15","author":"Malik","year":"2009","journal-title":"Liver Transplant"},{"key":"10.1016\/j.jceh.2024.101432_bib8","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1007\/s10620-018-5413-9","article-title":"Incidence of recurrent NASH-related allograft cirrhosis","volume":"64","author":"Kakar","year":"2019","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.jceh.2024.101432_bib9","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1111\/j.1600-6143.2004.00432.x","article-title":"Non-alcoholic fatty liver disease, non-alcoholic steatohepatitis and orthotopic liver transplantation","volume":"4","author":"Burke","year":"2004","journal-title":"Am J Transplant"},{"key":"10.1016\/j.jceh.2024.101432_bib10","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1002\/lt.23936","article-title":"Recurrent or de novo nonalcoholic fatty liver disease after liver transplantation: natural history based on liver biopsy analysis","volume":"20","author":"Vallin","year":"2014","journal-title":"Liver Transplant"},{"key":"10.1016\/j.jceh.2024.101432_bib11","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1111\/j.1432-2277.2004.00067.x","article-title":"Weight gain and obesity after liver transplantation","volume":"18","author":"Richards","year":"2005","journal-title":"Transpl Int"},{"key":"10.1016\/j.jceh.2024.101432_bib12","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1097\/00007890-199104000-00012","article-title":"Excessive weight gain after liver transplantation","volume":"51","author":"Palmer","year":"1991","journal-title":"Transplantation"},{"key":"10.1016\/j.jceh.2024.101432_bib13","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1016\/j.cgh.2013.06.025","article-title":"Patatin-like phospholipase domain-containing protein 3 rs738409-G in recipients of liver transplants is a risk factor for graft steatosis","volume":"11","author":"Finkenstedt","year":"2013","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2024.101432_bib14","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/j.1432-2277.2012.01576.x","article-title":"Metabolic syndrome and its association with fatty liver disease after orthotopic liver transplantation","volume":"26","author":"Sprinzl","year":"2013","journal-title":"Transpl Int"},{"key":"10.1016\/j.jceh.2024.101432_bib15","first-page":"CD005161","article-title":"Cyclosporin versus tacrolimus for liver transplanted patients","volume":"2006","author":"Haddad","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jceh.2024.101432_bib16","doi-asserted-by":"crossref","first-page":"2873","DOI":"10.1097\/TP.0000000000001913","article-title":"Everolimus is associated with less weight gain than tacrolimus 2 Years after liver transplantation: results of a randomized multicenter study","volume":"101","author":"Charlton","year":"2017","journal-title":"Transplantation"},{"key":"10.1016\/j.jceh.2024.101432_bib17","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1097\/TP.0000000000002485","article-title":"Management of recurrent and de novo NAFLD\/NASH after liver transplantation","volume":"103","author":"Germani","year":"2019","journal-title":"Transplantation"},{"key":"10.1016\/j.jceh.2024.101432_bib18","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1148\/radiol.10091790","article-title":"Assessment of hepatic steatosis in patients undergoing liver resection: comparison of US, CT, T1-weighted dual-echo MR imaging, and point-resolved 1H MR spectroscopy","volume":"256","author":"van Werven","year":"2010","journal-title":"Radiology"},{"key":"10.1016\/j.jceh.2024.101432_bib19","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0185192","article-title":"Performance of transient elastography and serum fibrosis biomarkers for non-invasive evaluation of recurrent fibrosis after liver transplantation: a meta-analysis","volume":"12","author":"Bhat","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.jceh.2024.101432_bib20","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/hep.29367","article-title":"The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases","volume":"67","author":"Chalasani","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2024.101432_bib21","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1002\/hep.29848","article-title":"Long-term outcomes of patients undergoing simultaneous liver transplantation and sleeve gastrectomy","volume":"68","author":"Zamora-Valdes","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2024.101432_bib22","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1007\/s00125-011-2446-4","article-title":"Impact of current treatments on liver disease, glucose metabolism and cardiovascular risk in non-alcoholic fatty liver disease (NAFLD): a systematic review and meta-analysis of randomised trials","volume":"55","author":"Musso","year":"2012","journal-title":"Diabetologia"},{"key":"10.1016\/j.jceh.2024.101432_bib23","doi-asserted-by":"crossref","DOI":"10.1097\/LVT.0000000000000110","article-title":"Saroglitazar improves nonalcoholic fatty liver disease and metabolic health in liver transplant recipients","volume":"29","author":"Siddiqui","year":"2023","journal-title":"Liver Transplant"},{"key":"10.1016\/j.jceh.2024.101432_bib24","doi-asserted-by":"crossref","first-page":"S132","DOI":"10.1016\/j.jceh.2023.07.188","article-title":"Safety and efficacy of dual PPAR- alpha agonist, saroglitazar, in management of NAFLD with diabetes and\/or dyslipidemia in liver transplant recipients","volume":"13","author":"Dhampalwar","year":"2023","journal-title":"J\u00a0Clin Exp Hepatol"},{"key":"10.1016\/j.jceh.2024.101432_bib25","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1111\/j.1600-6143.2009.02869.x","article-title":"Liver transplantation for alcoholic liver disease in Europe: a study from the ELTR (European liver transplant registry) , for ELITA and of behalf of ELTR liver transplant centers d","volume":"10","author":"Burra","year":"2010","journal-title":"Am J Transplant"},{"key":"10.1016\/j.jceh.2024.101432_bib26","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1097\/TP.0b013e31827afb3a","article-title":"Evolving frequency and outcomes of liver transplantation based on etiology of liver disease","volume":"95","author":"Singal","year":"2013","journal-title":"Transplantation"},{"key":"10.1016\/j.jceh.2024.101432_bib27","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1002\/lt.20386","article-title":"Alcohol recidivism impairs long-term patient survival after orthotopic liver transplantation for alcoholic liver disease","volume":"11","author":"Cuadrado","year":"2005","journal-title":"Liver Transplant"},{"key":"10.1016\/j.jceh.2024.101432_bib28","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1002\/lt.20934","article-title":"Long-term survival and predictors of relapse after orthotopic liver transplantation for alcoholic liver disease","volume":"13","author":"Pfitzmann","year":"2007","journal-title":"Liver Transplant"},{"key":"10.1016\/j.jceh.2024.101432_bib29","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1002\/lt.21278","article-title":"Meta-analysis of risk for relapse to substance use after transplantation of the liver or other solid organs","volume":"14","author":"Dew","year":"2008","journal-title":"Liver Transplant"},{"key":"10.1016\/j.jceh.2024.101432_bib30","doi-asserted-by":"crossref","first-page":"8033","DOI":"10.3748\/wjg.v20.i25.8033","article-title":"Challenges in transplantation for alcoholic liver disease","volume":"20","author":"Berlakovich","year":"2014","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jceh.2024.101432_bib31","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.jhep.2012.03.014","article-title":"Excessive alcohol consumption after liver transplantation impacts on long-term survival, whatever the primary indication","volume":"57","author":"Faure","year":"2012","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2024.101432_bib32","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s12664-016-0646-z","article-title":"Lower relapse rates with good post-transplant outcome in alcoholic liver disease: experience from a living donor liver transplant center","volume":"35","author":"Saigal","year":"2016","journal-title":"Indian J Gastroenterol"},{"key":"10.1016\/j.jceh.2024.101432_bib33","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S0168-8278(03)00088-6","article-title":"Alcohol relapse after liver transplantation for alcoholic liver disease: does it matter?","volume":"38","author":"Pageaux","year":"2003","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2024.101432_bib34","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.alcohol.2018.07.009","article-title":"Good outcome of living donor liver transplantation for severe alcoholic hepatitis not responding to medical management: a single center experience of 39 patients","volume":"77","author":"Choudhary","year":"2019","journal-title":"Alcohol"},{"key":"10.1016\/j.jceh.2024.101432_bib35","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1111\/j.1600-6143.2010.03232.x","article-title":"Trajectories of alcohol consumption following liver transplantation","volume":"10","author":"Dimartini","year":"2010","journal-title":"Am J Transplant"},{"key":"10.1016\/j.jceh.2024.101432_bib36","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1093\/alcalc\/agx098","article-title":"Alcohol relapse after liver transplantation for alcoholic cirrhosis-impact on liver graft and patient survival: a meta-analysis","volume":"53","author":"Kodali","year":"2018","journal-title":"Alcohol Alcohol"},{"key":"10.1016\/j.jceh.2024.101432_bib37","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1002\/lt.24425","article-title":"Severe alcoholic relapse after liver transplantation: what consequences on the graft? A study based on liver biopsies analysis","volume":"22","author":"Erard-Poinsot","year":"2016","journal-title":"Liver Transpl"},{"key":"10.1016\/j.jceh.2024.101432_bib38","doi-asserted-by":"crossref","DOI":"10.1002\/jhbp.1325","article-title":"Incidence and predictors of alcohol relapse following living donor liver transplantation for alcohol related liver disease","volume":"30","author":"Falari","year":"2023","journal-title":"J\u00a0Hepatobiliary Pancreat Sci"},{"key":"10.1016\/j.jceh.2024.101432_bib39","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1111\/ajt.17059","article-title":"Artificial intelligence to identify harmful alcohol use after early liver transplant for alcohol-associated hepatitis","volume":"22","author":"Lee","year":"2022","journal-title":"Am J Transplant"},{"key":"10.1016\/j.jceh.2024.101432_bib40","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12876-019-1050-9","article-title":"Alcohol relapse and its predictors after liver transplantation for alcoholic liver disease: a systematic review and meta-analysis","volume":"19","author":"Chuncharunee","year":"2019","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.jceh.2024.101432_bib41","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1002\/hep.30478","article-title":"Predicting low-risk for sustained alcohol use after early liver transplant for acute alcoholic hepatitis: the SALT score","volume":"69","author":"Lee","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2024.101432_bib42","first-page":"341","article-title":"[Stabilisation of abstinence by means of psychoeducation for patients with alcoholic liver disease awaiting liver transplantation]","volume":"52","author":"Erim","year":"2006","journal-title":"Z\u00a0Psychosom Med Psychother"},{"key":"10.1016\/j.jceh.2024.101432_bib43","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1080\/00365520410009591","article-title":"Long-term follow-up of patients with alcoholic liver disease after liver transplantation in Sweden: impact of structured management on recidivism","volume":"40","author":"Bj\u00f6rnsson","year":"2005","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.jceh.2024.101432_bib44","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1111\/acer.12117","article-title":"Liver transplantation in alcoholic patients: impact of an alcohol addiction unit within a liver transplant center","volume":"37","author":"Addolorato","year":"2013","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1016\/j.jceh.2024.101432_bib45","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1002\/lt.23747","article-title":"Substance abuse treatment and its association with relapse to alcohol use after liver transplantation","volume":"19","author":"Rodrigue","year":"2013","journal-title":"Liver Transplant"},{"key":"10.1016\/j.jceh.2024.101432_bib46","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1016\/S0140-6736(07)61814-5","article-title":"Effectiveness and safety of baclofen for maintenance of alcohol abstinence in alcohol-dependent patients with liver cirrhosis: randomised, double-blind controlled study","volume":"370","author":"Addolorato","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.jceh.2024.101432_bib47","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1111\/tri.13925","article-title":"Recurrence of primary sclerosing cholangitis after liver transplantation - analysing the European Liver Transplant Registry and beyond","volume":"34","author":"Visseren","year":"2021","journal-title":"Transpl Int"},{"key":"10.1016\/j.jceh.2024.101432_bib48","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1016\/j.jhep.2015.07.005","article-title":"Risk factors for recurrent primary sclerosing cholangitis after liver transplantation","volume":"63","author":"Ravikumar","year":"2015","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2024.101432_bib49","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.jceh.2020.02.002","article-title":"Good long-term outcomes in patients with primary sclerosing cholangitis undergoing living donor liver transplantation","volume":"10","author":"Choudhary","year":"2020","journal-title":"J\u00a0Clin Exp Hepatol"},{"key":"10.1016\/j.jceh.2024.101432_bib50","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1007\/s12072-022-10442-4","article-title":"Good outcomes of living donor liver transplant in primary sclerosing cholangitis: an experience from North India","volume":"17","author":"Jadaun","year":"2023","journal-title":"Hepatol Int"},{"key":"10.1016\/j.jceh.2024.101432_bib51","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1016\/S0140-6736(02)11861-7","article-title":"Risk factors for recurrence of primary sclerosing cholangitis of liver allograft","volume":"360","author":"Vera","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.jceh.2024.101432_bib52","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1002\/lt.21260","article-title":"Risk factors for recurrence of primary sclerosing cholangitis after liver transplantation","volume":"14","author":"Cholongitas","year":"2008","journal-title":"Liver Transplant"},{"key":"10.1016\/j.jceh.2024.101432_bib53","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1002\/lt.21679","article-title":"A\u00a0re-evaluation of the risk factors for the recurrence of primary sclerosing cholangitis in liver allografts","volume":"15","author":"Alabraba","year":"2009","journal-title":"Liver Transplant"},{"key":"10.1016\/j.jceh.2024.101432_bib54","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1002\/lt.21394","article-title":"Risk factors for recurrence of primary sclerosing cholangitis after liver transplantation","volume":"14","author":"Alexander","year":"2008","journal-title":"Liver Transplant"},{"key":"10.1016\/j.jceh.2024.101432_bib55","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1002\/lt.20444","article-title":"Recurrent primary sclerosing cholangitis after liver transplantation: a magnetic resonance cholangiography study with analyses of predictive factors","volume":"11","author":"Brandsaeter","year":"2005","journal-title":"Liver Transplant"},{"key":"10.1016\/j.jceh.2024.101432_bib56","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1097\/00007890-199811270-00006","article-title":"Recurrent primary sclerosing cholangitis after orthotopic liver transplantation: is chronic rejection part of the disease process?","volume":"66","author":"Jeyarajah","year":"1998","journal-title":"Transplantation"},{"key":"10.1016\/j.jceh.2024.101432_bib57","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1002\/lt.24496","article-title":"Recurrent primary sclerosing cholangitis in the Adult-to-Adult Living Donor Liver Transplantation Cohort Study: comparison of risk factors between living and deceased donor recipients","volume":"22","author":"Gordon","year":"2016","journal-title":"Liver Transplant"},{"key":"10.1016\/j.jceh.2024.101432_bib58","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1002\/lt.24350","article-title":"Biliary strictures and recurrence after liver transplantation for primary sclerosing cholangitis: a retrospective multicenter analysis","volume":"22","author":"Hildebrand","year":"2016","journal-title":"Liver Transplant"},{"key":"10.1016\/j.jceh.2024.101432_bib59","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.2214\/ajr.166.5.8615253","article-title":"Cholangiographic features of biliary strictures after liver transplantation for primary sclerosing cholangitis: evidence of recurrent disease","volume":"166","author":"Sheng","year":"1996","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.jceh.2024.101432_bib60","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/S1051-0443(91)72237-9","article-title":"Biliary strictures in hepatic transplantation","volume":"2","author":"McDonald","year":"1991","journal-title":"J\u00a0Vasc Intervent Radiol"},{"key":"10.1016\/j.jceh.2024.101432_bib61","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1148\/radiology.177.1.2399328","article-title":"Hilar biliary strictures after liver transplantation: cholangiography and percutaneous treatment","volume":"177","author":"Ward","year":"1990","journal-title":"Radiology"},{"key":"10.1016\/j.jceh.2024.101432_bib62","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1148\/radiology.167.2.3282255","article-title":"Biliary complications after liver transplantation in patients with preexisting sclerosing cholangitis","volume":"167","author":"Letourneau","year":"1988","journal-title":"Radiology"},{"key":"10.1016\/j.jceh.2024.101432_bib63","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1148\/radiology.191.3.8184054","article-title":"Intrahepatic biliary strictures after liver transplantation","volume":"191","author":"Campbell","year":"1994","journal-title":"Radiology"},{"key":"10.1016\/j.jceh.2024.101432_bib64","doi-asserted-by":"crossref","first-page":"297","DOI":"10.2214\/ajr.161.2.8333366","article-title":"Biliary strictures in hepatic transplants: prevalence and types in patients with primary sclerosing cholangitis vs those with other liver diseases","volume":"161","author":"Sheng","year":"1993","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.jceh.2024.101432_bib65","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1002\/hep.510290427","article-title":"Recurrence of primary sclerosing cholangitis following liver transplantation","volume":"29","author":"Graziadei","year":"1999","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2024.101432_bib66","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1053\/j.gastro.2005.10.018","article-title":"24-norUrsodeoxycholic acid is superior to ursodeoxycholic acid in the treatment of sclerosing cholangitis in Mdr2 (Abcb4) knockout mice","volume":"130","author":"Fickert","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jceh.2024.101432_bib67","first-page":"1","article-title":"Successful treatment of recurrent primary sclerosing cholangitis after orthotopic liver transplantation with oral vancomycin","volume":"2013","author":"Davies","year":"2013","journal-title":"Case Rep Transplant"},{"key":"10.1016\/j.jceh.2024.101432_bib68","article-title":"Efficacy of oral vancomycin in recurrent primary sclerosing cholangitis following liver transplantation","volume":"2017","author":"Hey","year":"2017","journal-title":"Case Reports"},{"key":"10.1016\/j.jceh.2024.101432_bib69","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1097\/01.TP.0000113807.74942.D2","article-title":"Roux-en-Y Choledochojejunostomy is the method of choice for biliary reconstruction in liver transplantation for primary sclerosing cholangitis","volume":"77","author":"Welsh","year":"2004","journal-title":"Transplantation"},{"key":"10.1016\/j.jceh.2024.101432_bib70","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1016\/j.transproceed.2013.01.066","article-title":"Roux-en-Y choledochojejunostomy versus duct-to-duct biliary anastomosis in liver transplantation for primary sclerosing cholangitis: a meta-analysis","volume":"45","author":"Wells","year":"2013","journal-title":"Transplant Proc"},{"key":"10.1016\/j.jceh.2024.101432_bib71","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1111\/tri.12513","article-title":"Meta-analysis of Duct-to-duct versus Roux-en-Y biliary reconstruction following liver transplantation for primary sclerosing cholangitis","volume":"28","author":"Pandanaboyana","year":"2015","journal-title":"Transpl Int"},{"key":"10.1016\/j.jceh.2024.101432_bib72","doi-asserted-by":"crossref","DOI":"10.1097\/TXD.0000000000000760","article-title":"Rituximab induction to prevent the recurrence of PSC after liver transplantation\u2014the lessons learned from ABO-incompatible living donor liver transplantation","volume":"4","author":"Yamada","year":"2018","journal-title":"Transplant Direct"},{"key":"10.1016\/j.jceh.2024.101432_bib73","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1111\/j.1365-2036.2006.03104.x","article-title":"Type I autoimmune hepatitis: clinical course and outcome in an Italian multicentre study","volume":"24","author":"Floreani","year":"2006","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jceh.2024.101432_bib74","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1053\/gast.1996.v110.pm8608895","article-title":"Prognosis of histological cirrhosis in type 1 autoimmune hepatitis","volume":"110","author":"Roberts","year":"1996","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jceh.2024.101432_bib75","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.1053\/j.gastro.2011.02.065","article-title":"Long-term outcomes of patients with autoimmune hepatitis managed at a nontransplant center","volume":"140","author":"Hoeroldt","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jceh.2024.101432_bib76","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1002\/lt.500010305","article-title":"Recurrence of autoimmune hepatitis following liver transplantation","volume":"1","author":"Devlin","year":"1995","journal-title":"Liver Transplant Surg"},{"key":"10.1016\/j.jceh.2024.101432_bib77","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1097\/00007890-198404000-00009","article-title":"Recurrence of autoimmune chronic active hepatitis following orthotopic liver grafting","volume":"37","author":"Neuberger","year":"1984","journal-title":"Transplantation"},{"key":"10.1016\/j.jceh.2024.101432_bib78","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0168-8278(99)80017-8","article-title":"Long-term follow-up after liver transplantation for autoimmune hepatitis: evidence of recurrence of primary disease","volume":"30","author":"Ratziu","year":"1999","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2024.101432_bib79","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1053\/jlts.2002.32981","article-title":"Incidence and recurrence of autoimmune\/alloimmune hepatitis in liver transplant recipients","volume":"8","author":"Molmenti","year":"2002","journal-title":"Liver Transplant"},{"key":"10.1016\/j.jceh.2024.101432_bib80","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1002\/lt.20910","article-title":"Recurrence of autoimmune liver disease after liver transplantation: a systematic review","volume":"12","author":"Gautam","year":"2006","journal-title":"Liver Transplant"},{"key":"10.1016\/j.jceh.2024.101432_bib81","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/j.1399-0012.2004.00117.x","article-title":"Long-term outcome of liver transplantation for autoimmune hepatitis","volume":"18","author":"Vogel","year":"2004","journal-title":"Clin Transplant"},{"key":"10.1016\/j.jceh.2024.101432_bib82","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1002\/lt.21525","article-title":"Liver transplantation for autoimmune hepatitis and the success of aggressive corticosteroid withdrawal","volume":"14","author":"Campsen","year":"2008","journal-title":"Liver Transplant"},{"key":"10.1016\/j.jceh.2024.101432_bib83","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1053\/jlts.2001.21449","article-title":"Recurrent autoimmune hepatitis after orthotopic liver transplantation","volume":"7","author":"Gonz\u00e1lez-Koch","year":"2001","journal-title":"Liver Transplant"},{"key":"10.1016\/j.jceh.2024.101432_bib84","doi-asserted-by":"crossref","DOI":"10.1097\/TXD.0000000000001160","article-title":"HLA-DR mismatch and black race are associated with recurrent autoimmune hepatitis after liver transplantation","volume":"7","author":"McCabe","year":"2021","journal-title":"Transplant Direct"},{"key":"10.1016\/j.jceh.2024.101432_bib85","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1097\/00007890-199201000-00027","article-title":"Disease recurrence and rejection following liver transplantation for autoimmune chronic active liver disease","volume":"53","author":"Wright","year":"1992","journal-title":"Transplantation"},{"key":"10.1016\/j.jceh.2024.101432_bib86","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1002\/lt.21796","article-title":"Risk factors for recurrence of autoimmune hepatitis after liver transplantation","volume":"15","author":"Montano-Loza","year":"2009","journal-title":"Liver Transplant"},{"key":"10.1016\/j.jceh.2024.101432_bib87","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1053\/jhep.2000.9077","article-title":"Liver transplantation for autoimmune hepatitis: a long-term pathologic study","volume":"32","author":"Ayata","year":"2000","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2024.101432_bib88","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/hep.22435","article-title":"Long-term outcome of human leukocyte antigen mismatching in liver transplantation: results of the national institute of diabetes and digestive and kidney diseases liver transplantation database","volume":"48","author":"Balan","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2024.101432_bib89","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1002\/cld.1234","article-title":"Alloimmune versus autoimmune hepatitis following liver transplantation","volume":"20","author":"Harrington","year":"2022","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.jceh.2024.101432_bib90","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1002\/lt.24323","article-title":"Longterm corticosteroid use after liver transplantation for autoimmune hepatitis is safe and associated with a lower incidence of recurrent disease","volume":"22","author":"Krishnamoorthy","year":"2016","journal-title":"Liver Transplant"},{"key":"10.1016\/j.jceh.2024.101432_bib91","doi-asserted-by":"crossref","DOI":"10.1002\/hep.20028","article-title":"Unusual suspects in primary biliary cirrhosis","volume":"39","author":"Vergani","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2024.101432_bib92","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1002\/hep.22178","article-title":"Mortality attributable to cholestatic liver disease in the United States","volume":"47","author":"Mendes","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2024.101432_bib93","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1097\/01.TP.0000090867.83666.F7","article-title":"The changing clinical presentation of recurrent primary biliary cirrhosis after liver transplantation","volume":"76","author":"Sanchez","year":"2003","journal-title":"Transplantation"},{"key":"10.1016\/j.jceh.2024.101432_bib94","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1053\/jlts.2001.25357","article-title":"Disease recurrence after living liver transplantation for primary biliary cirrhosis: a clinical and histological follow-up study","volume":"7","author":"Hashimoto","year":"2001","journal-title":"Liver Transplant"},{"key":"10.1016\/j.jceh.2024.101432_bib95","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S1568-9972(02)00103-9","article-title":"Liver transplantation for primary biliary cirrhosis","volume":"2","author":"Neuberger","year":"2003","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.jceh.2024.101432_bib96","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1111\/j.1432-2277.2007.00628.x","article-title":"The Impact of Disease Recurrence on Graft Survival Following Liver Transplantation: A Single Centre Experience","volume":"21","author":"Rowe","year":"2008","journal-title":"Transpl Int"},{"key":"10.1016\/j.jceh.2024.101432_bib97","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1002\/lt.20856","article-title":"Impact of human leukocyte antigen mismatching on outcomes of living donor liver transplantation for primary biliary cirrhosis","volume":"13","author":"Morioka","year":"2007","journal-title":"Liver Transplant"},{"key":"10.1016\/j.jceh.2024.101432_bib98","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1002\/lt.21960","article-title":"Primary biliary cirrhosis after liver transplantation: influence of immunosuppression and human leukocyte antigen locus disparity","volume":"16","author":"Manousou","year":"2010","journal-title":"Liver Transplant"},{"key":"10.1016\/j.jceh.2024.101432_bib99","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1002\/lt.21118","article-title":"Impact of human leukocyte antigen mismatching on outcomes of living donor liver transplantation for primary biliary cirrhosis","volume":"13","author":"Hashimoto","year":"2007","journal-title":"Liver Transplant"},{"key":"10.1016\/j.jceh.2024.101432_bib100","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/S0168-8278(05)80206-5","article-title":"Recurrence of primary biliary cirrhosis after liver transplantation following FK506-based immunosuppression","volume":"17","author":"Wong","year":"1993","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2024.101432_bib101","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0168-8278(05)80244-2","article-title":"Primary biliary cirrhosis. Histological evidence of disease recurrence after liver transplantation","volume":"18","author":"Hubscher","year":"1993","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2024.101432_bib102","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1002\/lt.21124","article-title":"Long-term survival and impact of ursodeoxycholic acid treatment for recurrent primary biliary cirrhosis after liver transplantation","volume":"13","author":"Charatcharoenwitthaya","year":"2007","journal-title":"Liver Transplant"},{"key":"10.1016\/j.jceh.2024.101432_bib103","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1053\/jhep.2001.20894","article-title":"Transplantation for primary biliary cirrhosis: retrospective analysis of 400 patients in a single center","volume":"33","author":"Liermann Garcia","year":"2001","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2024.101432_bib104","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1002\/lt.20123","article-title":"Immunosuppression affects the rate of recurrent primary biliary cirrhosis after liver transplantation","volume":"10","author":"Neuberger","year":"2004","journal-title":"Liver Transplant"},{"key":"10.1016\/j.jceh.2024.101432_bib105","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/j.1399-0012.2005.00471.x","article-title":"Long-term follow-up after recurrence of primary biliary cirrhosis after liver transplantation in 100 patients","volume":"20","author":"Jacob","year":"2006","journal-title":"Clin Transplant"},{"key":"10.1016\/j.jceh.2024.101432_bib106","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1053\/jlts.2003.36392","article-title":"Liver transplantation for primary biliary cirrhosis: a long-term pathologic study","volume":"9","author":"Khettry","year":"2003","journal-title":"Liver Transplant"},{"key":"10.1016\/j.jceh.2024.101432_bib107","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1053\/jlts.2003.50132","article-title":"The effect of immunosuppressive regimens on the recurrence of primary biliary cirrhosis after liver transplantation","volume":"9","author":"Levitsky","year":"2003","journal-title":"Liver Transplant"},{"key":"10.1016\/j.jceh.2024.101432_bib108","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1111\/j.1600-6143.2010.03038.x","article-title":"Recurrent primary biliary cirrhosis after liver transplantation","volume":"10","author":"Silveira","year":"2010","journal-title":"Am J Transplant"},{"key":"10.1016\/j.jceh.2024.101432_bib109","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1053\/jlts.2003.50213","article-title":"Recurrence of primary biliary cirrhosis after liver transplantation: histologic estimate of incidence and natural history","volume":"9","author":"Sylvestre","year":"2003","journal-title":"Liver Transplant"},{"key":"10.1016\/j.jceh.2024.101432_bib110","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0168-8278(05)80056-X","article-title":"Antimitochondrial antibody profiles in patients with primary biliary cirrhosis before orthotopic liver transplantation and titres of antimitochondrial antibody-subtypes after transplantation","volume":"20","author":"Klein","year":"1994","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2024.101432_bib111","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1002\/hep.510240517","article-title":"Immunohistochemical evidence of disease recurrence after liver transplantation for primary biliary cirrhosis","volume":"24","author":"van de Water","year":"1996","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2024.101432_bib112","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1016\/j.jhep.2015.07.038","article-title":"Preventive administration of UDCA after liver transplantation for primary biliary cirrhosis is associated with a lower risk of disease recurrence","volume":"63","author":"Bosch","year":"2015","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2024.101432_bib113","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.jhep.2020.03.043","article-title":"Long-term impact of preventive UDCA therapy after transplantation for primary biliary cholangitis","volume":"73","author":"Corpechot","year":"2020","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2024.101432_bib114","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1002\/lt.25935","article-title":"Ursodeoxycholic acid decreases incidence of primary biliary cholangitis and biliary complications after liver transplantation: a meta-analysis","volume":"27","author":"Pedersen","year":"2021","journal-title":"Liver Transplant"},{"key":"10.1016\/j.jceh.2024.101432_bib115","doi-asserted-by":"crossref","first-page":"2806","DOI":"10.1007\/s00268-022-06709-4","article-title":"Living donor liver transplantation for Budd-Chiari syndrome: a propensity score-matched analysis","volume":"46","author":"Gunasekaran","year":"2022","journal-title":"World J Surg"},{"key":"10.1016\/j.jceh.2024.101432_bib116","doi-asserted-by":"crossref","DOI":"10.1097\/00000658-199001000-00007","article-title":"Liver transplantation for the Budd-Chiari syndrome","volume":"211","author":"Halff","year":"1990","journal-title":"Ann Surg"},{"key":"10.1016\/j.jceh.2024.101432_bib117","article-title":"Orthotopic liver transplantation for Budd-Chiari syndrome: observations from a 30-year liver transplant program","volume":"57","author":"Ibach","year":"2021","journal-title":"Medicina (B Aires)"},{"key":"10.1016\/j.jceh.2024.101432_bib118","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/0016-5085(83)90093-8","article-title":"Budd-Chiari syndrome recurring in a transplanted liver","volume":"84","author":"Seltman","year":"1983","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jceh.2024.101432_bib119","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1111\/j.1432-2277.2003.tb00260.x","article-title":"Recurrence of Budd-Chiari syndrome after liver transplantation in paroxysmal nocturnal hemoglobinuria","volume":"16","author":"Bahr","year":"2003","journal-title":"Transpl Int"}],"container-title":["Journal of Clinical and Experimental Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0973688324000896?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0973688324000896?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,6]],"date-time":"2024-11-06T16:20:51Z","timestamp":1730910051000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0973688324000896"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":119,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["S0973688324000896"],"URL":"https:\/\/doi.org\/10.1016\/j.jceh.2024.101432","relation":{},"ISSN":["0973-6883"],"issn-type":[{"value":"0973-6883","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Recurrence of Primary Disease After Adult Liver Transplant \u2013 Risk Factors, Early Diagnosis, Management, and Prevention","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical and Experimental Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jceh.2024.101432","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Indian National Association for Study of the Liver. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"101432"}}